Aditxt, Inc. (ADTX) vs HCW Biologics Inc. (HCWB)

Aditxt, Inc. and HCW Biologics Inc. are both Biotechnology companies. Aditxt, Inc. and HCW Biologics Inc. are of similar size ($4.4M and $4.2M). HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against −74.2%. HCW Biologics Inc. has the higher net margin (−329.4% vs −372,998.6%) and the lower return on invested capital (−36.2% vs 0.00%). Across the 15 metrics below, HCW Biologics Inc. leads on 8 and Aditxt, Inc. on 7.

Valuation

Metric ADTX HCWB Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.38 11.47
P/B n/m 0.35 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 65.38 1.30 10.73
Earnings yield 0.00% (1,429.91%) (28.84%)
Free cash flow yield 0.00% (483.74%) (23.03%)

Profitability

Metric ADTX HCWB Biotechnology median
Gross margin 20.28% 95.91% 65.16%
Operating margin (128,143.36%) (114.02%) 0.00%
Net margin (372,998.60%) (329.38%) 0.00%
Free cash flow margin (129,979.72%) (180.57%) 0.00%
Return on equity 549.59% (600.32%) (57.72%)
Return on assets (236.38%) (79.52%) (49.22%)
Return on invested capital 0.00% (36.15%) 0.00%

Growth

Metric ADTX HCWB Biotechnology median
Revenue growth (TTM) (74.19%) 706.96% 5.64%
EPS growth (last fiscal year) 99.99% 65.49% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX HCWB Biotechnology median
Debt to equity 0.00 0.88 0.00
Current ratio 0.06 0.06 4.73
Net debt to EBITDA 0.18 (0.40) 0.96

Dividend

Metric ADTX HCWB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADTX HCWB Biotechnology median
Market cap 4.39m 4.18m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack